You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patient demography and clinical presentation

From: Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Characteristics Values
Age (years) 63(range 42–85)
Gender (male/female) 27/3 (90%/10.0%)
Karnofsky performance score ≥ 70 30 (100%)
Pathology of primary tumor Lesions per patient
 ▪ Squamous cell carcinoma 7(23.3%) ▪ 1 28 (93.3%)
 ▪ Adenocarcinoma 12 (40.0%) ▪ > 1 2 (6.7%)
 ▪ Small cell lung cancer 5 (16.7%) Systemic therapy after SBRT
 ▪ Adenosquamous carcinoma 3 (10.0%)
 ▪ Unknown 3 (10.0%) ▪ Yes 18 (60%)
Location of AGMs ▪ None 12 (40%)
 ▪ Left 16 (53.3%) Metastases in other sites
 ▪ Right 12 (40%) ▪ Yes 15 (50%)
 ▪ Left and right 2 (6.7%) ▪ No 15 (50%)
Symptoms SBRT for other sites  
 ▪ Presented 14 (46.7%) ▪ Yes 9 (30%)
 ▪ None 16 (53.3%) ▪ No 21 (70%)